13:17 EDT Capricor halted for volatility after sinking 37% to $7.58
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics trading halted, volatility trading pause
- Capricor Therapeutics announces four-year data from HOPE-2 OLE study
- FDA’s Nicole Verdun placed on administrative leave, STAT reports
- Capricor Therapeutics announces ODD to Deramiocel
- Capricor treatment of Becker muscular dystrophy granted orphan designation